SITE012-0019

SITE012 (BRA) › SITE012-0019

SITE012-0019

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE012 (BRA) · Dr. Kowalski
consented 2025-09-08

enrolled

AEs

4

Serious

0

Dropout signal

–

Adverse events

4

Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-03-02 (study day 344); relationship: NOT RELATED

mild assessed

Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-02-20 (study day 334); relationship: RELATED

mild assessed

Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-02-03 (study day 317); relationship: NOT RELATED

mild assessed

Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-11-26 (study day 248); relationship: not assessed

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.